Company intelligence / Profile preview

Sanai Health Industry Group

Grand Cayman, Cayman Islands1889hk.com ↗

Ownership: Private
Employees: ~164
Development stage: Other

Overview

Sanai Health Industry Group is a Hong Kong-based investment holding company focused on the development, manufacturing, marketing and sale of branded prescription and non-prescription drugs—including Chinese pharmaceuticals—in China and Hong Kong. It also provides finance leasing services and genetic testing/molecular diagnostic services. The group’s revenue has declined recently; it reported negative earnings for 2024 but remains operational with commercialized products.

Modalities: Small moleculeTraditional medicine
Industry: Biotech

Beyond the preview

Go deeper on Sanai Health Industry Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanai Health Industry Group.

Explore the full profile